By: Hannah Daniel
Avenda's chief operating officer Brit Berry-Pusey spoke to Medtech Insight about the company's CPT III code for its prostate cancer mapping AI and how regulatory bodies can align to support innovators.
Hannah Daniel is a journalist whose work has appeared in Informa. She covers a wide range of topics, including medical technology, healthcare regulations, and industry updates. Hannah's articles provide valuable insights and updates on the latest developments in the field, keeping readers informed and engaged.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Hannah's reporting focuses on healthcare and medical technology, with a strong emphasis on government announcements and industry updates. Her coverage also includes significant attention to FDA regulations, data breaches in the healthcare industry, and the integration of artificial intelligence in healthcare.
Given her focus on government announcements and press releases related to medical technology and FDA regulations, Hannah may be particularly interested in pitches that offer expert insights into new guidelines or policies within these areas. She is likely seeking sources who can provide informed perspectives on how recent developments will impact the healthcare industry.
It's worth noting that Hannah does not appear to have a specific geographic focus but covers topics relevant to the broader healthcare industry without geographical constraints.
This information evolves through artificial intelligence and human feedback. Improve this profile .